27
Oct
2014
New molecule approved by USFDA tilldate in 2014
| 2014 New Molecule Approved tilldate | ||||
| No. | Drug Name | Active Ingredient | Date | What It’s Used For |
| 34 | Esbriet | pirfenidone | 15-10-2014 | For the treatment of idiopathic pulmonary fibrosis (IPF) |
| 33 | Ofev | nintedanib | 15-10-2014 | For the treatment of idiopathic pulmonary fibrosis (IPF) |
| 32 | Lumason | sulfur hexafluoride lipid microsphere | 10-10-2014 | For patients whose ultrasound image of the heart (echocardiograms) are hard to see with ultrasound waves |
| 31 | Akynzeo | netupitant and palonosetron | 10-10-2014 | To treat nausea and vomiting in patients undergoing cancer chemotherapy |
| 30 | Harvoni | ledipasvir/sofosbuvir | 10-10-2014 | To treat chronic hepatitis C virus (HCV) genotype 1 infection |
| 29 | Trulicity | dulaglutide | 18-09-2014 | To treat adults with type 2 diabetes. |
| 28 | Movantik | naloxegol | 16-09-2014 | To treat opioid-induced constipation in adults with chronic non-cancer pain. |
| 27 | Keytruda | pembrolizumab | 04-09-2014 | For treatment of patients with advanced or unresectable melanoma who are no longer responding to other drugs. |
| 26 | Cerdelga | eliglustat | 19-08-2014 | For the long-term treatment of adult patients with the Type 1 form of Gaucher disease |
| 25 | Plegridy | peginterferon beta-1a | 15-08-2014 | For the treatment of patients with relapsing forms of multiple sclerosis |
| 24 | Belsomra | suvorexant | 13-08-2014 | To treat difficulty in falling and staying asleep (insomnia) |
| 23 | Orbactiv | oritavancin | 06-08-2014 | To treat adults with skin infections |
| 22 | Jardiance | empagliflozin | 01-08-2104 | To improve gylcemic control in adults with type 2 diabetes |
| 21 | Striverdi Respimat | olodaterol | 31-07-2014 | To treat chronic obstructive pulmonary disease |
| 20 | Zydelig | idelalisib | 23-07-2014 | To treat patients with trhee types of blood cancers |
| 19 | Kerydin | tavaborole | 07-07-2014 | For the topical treatment of onychomycosis of the toenails |
| 18 | Beleodaq | belinostat | 03-07-2014 | To treat patients with peripheral T-cell lymphoma (PTCL) |
| 17 | Sivextro (tablet) | tedizolid phosphate | 20-06-2014 | To treat adults with skin infections |
| 16 | Jublia | efinaconazole | 06-06-2014 | Treat mild to moderate onychomycosis (fungal infection) |
| 15 | Dalvance | dalbavancin | 23-05-2014 | To treat adults with skin infections |
| 14 | Entyvio | vedolizumab | 20-05-2014 | To treat adult patients with moderate to severe ulcerative colitis and adult patients with moderate to severe Crohn‘s disease |
| 13 | Zontivity | vorapaxar | 08-05-2014 | To reduce the risk of heart attacks and stroke in high-risk patients |
| 12 | Zykadia | ceritinib | 29-04-2014 | To treat patients with a certain type of late-stage (metastatic) non-small cell lung cancer (NSCLC) |
| 11 | Sylvant | siltuximab | 23-04-2014 | To treat patients with multicentric Castleman’s disease (MCD), a rare disorder similar to lymphoma (cancer of the lymph nodes) |
| 10 | Cyramza | ramucirumab | 21-04-2014 | To treat patients with advanced stomach cancer or gastroesophageal junction adenocarcinoma |
| 9 | Tanzeum | albiglutide | 15-04-2014 | To improve glycemic control, along with diet and exercise, in adults with type 2 diabetes |
| 8 | Otezla | apremilast | 21-03-2014 | To treat adults with active psoriatic arthritis (PsA) |
| 7 | Impavido | miltefosine | 19-03-2014 | To treat a tropical disease called leishmaniasis |
| 6 | Neuraceq | florbetaben F 18 injection | 19-03-2014 | For Positron EmissionTomography (PET) imaging of the brain |
| 5 | Myalept | metreleptin for injection | 24-02-2014 | To treat the complications of leptin deficiency |
| 4 | Northera | droxidopa | 18-02-2014 | To treat neurogenic orthostatic hypotension (NOH) |
| 3 | Vimizim | elosulfase alfa | 14-02-2014 | Treatment for Mucopolysaccharidosis Type IVA (Morquio A syndrome) |
| 2 | Hetlioz | tasimelteon | 31-01-2014 | To treat non-24- hour sleep-wake disorder (“non-24”) in totally blind individuals. Non-24 is a chronic circadian rhythm (body clock) disorder in the blind that causes problems with the timing of sleep. |
| 1 | Farxiga | dapaglifozin | 08-01-2014 | To improve glycemic control, along with diet and exercise, in adults with type 2 diabetes |
Reference: USFDA official notification
Related Articles
About Post Author
